TMED7-TICAM2 - middle region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TMED7-TICAM2 - middle region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TMED7-TICAM2 - middle region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This locus represents naturally occurring read-through transcription between the neighboring transmembrane emp24 protein transport domain containing 7 (TMED7) and toll-like receptor adaptor molecule 2 (TICAM2) genes. Alternative splicing results in multiple transcript variants, one of which encodes a fusion protein that shares sequence identity with the products of each individual gene. This fusion product functions to negatively regulate the adaptor MyD88-independent toll-like receptor 4 pathway. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human TMED7-TICAM2 |
| Other Names | [TRAM adaptor with GOLD domain isoform 1; TIR domain-containing adapter molecule 2; TRAM adaptor with GOLD domain; TMED7-TICAM2 readthrough; Putative NF-kappa-B-activating protein 502; TRIF-related adapter molecule; Toll-like receptor adaptor protein 3; Toll/interleukin-1 receptor domain-containing protein; MyD88-4] |
| Gene, Accession # | [TMED7-TICAM2], Gene ID: 100302736, NCBI: NP_001157940.1, UniProt: Q86XR7 |
| Catalog # | MBS3221066 |
| Price | $335 |
| Order / More Info | TMED7-TICAM2 - middle region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies